134 related articles for article (PubMed ID: 26418334)
21. Colorectal cancer screening in rural and remote areas: analysis of the National Bowel Cancer Screening Program data for South Australia.
Martini A; Javanparast S; Ward PR; Baratiny G; Gill T; Cole S; Tsourtos G; Aylward P; Jiwa M; Misan G; Wilson C; Young GP
Rural Remote Health; 2011; 11(2):1648. PubMed ID: 21585228
[TBL] [Abstract][Full Text] [Related]
22. Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre.
Ellul P; Fogden E; Simpson CL; Nickerson CL; McKaig BC; Swarbrick ET; Veitch AM
Colorectal Dis; 2010 May; 12(5):420-2. PubMed ID: 19843116
[TBL] [Abstract][Full Text] [Related]
23. Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal Cancer.
Mendis S; Hong W; Ananda S; Faragher I; Jones I; Croxford M; Steel M; Jalali A; Gard G; To YH; Lee M; Kosmider S; Wong R; Tie J; Gibbs P
JNCI Cancer Spectr; 2022 Jan; 6(1):. PubMed ID: 35699496
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of FOB testing in eastern-Australian general practice patients: what has a national bowel cancer screening program delivered?
Paul CL; Carey ML; Russell G; D'Este C; Sanson-Fisher RW; Zwar N
Health Promot J Austr; 2015 Apr; 26(1):39-44. PubMed ID: 25818504
[TBL] [Abstract][Full Text] [Related]
25. Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial.
McIntosh JG; Jenkins M; Wood A; Chondros P; Campbell T; Wenkart E; O'Reilly C; Dixon I; Toner J; Martinez-Gutierrez J; Govan L; Emery JD
Br J Gen Pract; 2024 Apr; 74(741):e275-e282. PubMed ID: 38164588
[TBL] [Abstract][Full Text] [Related]
26. Impact of a mass media campaign on participation rates in a National Bowel Cancer Screening Program: a field experiment.
Durkin SJ; Broun K; Spittal MJ; Wakefield MA
BMJ Open; 2019 Jan; 9(1):e024267. PubMed ID: 30813110
[TBL] [Abstract][Full Text] [Related]
27. Screening colonoscopy in Australia.
Singh R; Mangira D; Kawano H; Matsuda T
Dig Endosc; 2015 Apr; 27 Suppl 1():30-4. PubMed ID: 25523496
[TBL] [Abstract][Full Text] [Related]
28. Equity of colorectal cancer screening: which groups have inequitable participation and what can we do about it?
Ward PR; Javanparast S; Wilson C
Aust J Prim Health; 2011; 17(4):334-46. PubMed ID: 22112702
[TBL] [Abstract][Full Text] [Related]
29. Beliefs about bowel cancer among the target group for the National Bowel Cancer Screening Program in Australia.
Jalleh G; Donovan RJ; Lin C; Slevin T; Clayforth C; Pratt IS; Ledger M
Aust N Z J Public Health; 2010 Apr; 34(2):187-92. PubMed ID: 23331364
[TBL] [Abstract][Full Text] [Related]
30. Increasing bowel cancer screening participation: integrating population-wide, primary care and more targeted approaches.
Lofti-Jam KL; O'Reilly CL; Feng CS; Wakefield MA; Durkin S; Broun KH
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384890
[TBL] [Abstract][Full Text] [Related]
31. Engaging lower screening groups: a field experiment to evaluate the impact of a multiwave national campaign on participation in the National Bowel Cancer Screening Program.
Gascoyne C; Broun K; Morley B; Wyatt K; Feletto E; Durkin SJ
BMJ Open; 2023 Mar; 13(3):e065124. PubMed ID: 36921953
[TBL] [Abstract][Full Text] [Related]
32. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
33. Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia.
Lew JB; St John DJB; Macrae FA; Emery JD; Ee HC; Jenkins MA; He E; Grogan P; Caruana M; Greuter MJE; Coupé VMH; Canfell K
Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1450-1461. PubMed ID: 30190276
[TBL] [Abstract][Full Text] [Related]
34. Institutional (mis)trust in colorectal cancer screening: a qualitative study with Greek, Iranian, Anglo-Australian and Indigenous groups.
Ward PR; Coffey C; Javanparast S; Wilson C; Meyer SB
Health Expect; 2015 Dec; 18(6):2915-27. PubMed ID: 25271975
[TBL] [Abstract][Full Text] [Related]
35. Improved 5-year survival of patients with immunochemical faecal blood test-screen-detected colorectal cancer versus non-screening cancers in northern Italy.
Parente F; Vailati C; Boemo C; Bonoldi E; Ardizzoia A; Ilardo A; Tortorella F; Cereda D; Cremaschini M; Moretti R
Dig Liver Dis; 2015 Jan; 47(1):68-72. PubMed ID: 25306524
[TBL] [Abstract][Full Text] [Related]
36. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of patients aged 50–74 years with a request for an immunochemical faecal occult blood test in the Australian general practice setting.
Pollack A; Busingye D; Thistlethwaite J; Blogg S; Chidwick K
Aust Health Rev; 2022 Apr; 46(2):222-232. PubMed ID: 35220996
[TBL] [Abstract][Full Text] [Related]
38. Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia.
Worthington J; Feletto E; Lew JB; Broun K; Durkin S; Wakefield M; Grogan P; Harper T; Canfell K
Public Health; 2020 Feb; 179():90-99. PubMed ID: 31760206
[TBL] [Abstract][Full Text] [Related]
39. Colorectal cancers detected through screening are associated with lower stages and improved survival.
Lindebjerg J; Osler M; Bisgaard C
Dan Med J; 2014 Jan; 61(1):A4758. PubMed ID: 24393588
[TBL] [Abstract][Full Text] [Related]
40. Are screen detected colorectal cancers asymptomatic?
Harmston C; Akwei S; Barnes R; Goodyear S; Wong L
Colorectal Dis; 2010 May; 12(5):416-9. PubMed ID: 19220377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
